CN Bio, FDA expand collaboration to evaluate the PhysioMimix multi-organ microphysiological system
CN Bio, a leading organ-on-a-chip company and the U.S. Food and Drug Administration (FDA) have expanded their collaboration for the second time, with new research aiming to evaluate multi-organ microphysiological systems (MPS) and their applications using the PhysioMimix Multi-organ System. Building on the success of prior studies, the system will initially be investigated for improving […]
